Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
NCT07477691
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Phenylketonuria
Interventions
BIOLOGICAL:
Pegvaliase
DRUG:
Methotrexate
Sponsor
BioMarin Pharmaceutical